IL-6 also affects the metastatic potential of lung cancer cells by activating the JAK2/STAT3 signaling pathway, which impacts angiogenesis by increasing the expression of VEGF and bFGF [267,445,477,478,479,480,481,482,483]. The gene discussed is IL6; the disease is lung carcinoma.